200
Participants
Start Date
January 31, 2013
Primary Completion Date
April 30, 2017
Study Completion Date
October 31, 2017
Ciprofloxacin
Patients will be randomized 2:1 active comparator, Cipro, to placebo comparator.
placebo
Patients will be randomized 2:1 placebo comparator to active comparator, Cipro.
Houston Methodist Hospital, Houston
The Methodist Hospital Research Institute
OTHER